期刊文献+

口腔鳞状细胞癌患者60例血清MMP-9和TIMP-1水平及其临床意义 被引量:1

The Level of Serum MMP-9 and TIMP-1 in 60 Cases with Oral Squamous Cell Carcinoma and its Clinical Significance
原文传递
导出
摘要 [目的]探讨基质金属蛋白酶-9(MMP-9)及基质金属蛋白酶组织抑制因子-1(TIMP-1)在口腔鳞状细胞癌(OSCC)中的水平及意义。[方法]用ELISA法检测60例OSCC患者、26例口腔非典型增生患者术前及30名健康对照者血清中MMP-9、TIMP-1水平。[结果]OSCC患者血清MMP-9水平为21.67±4.21ng/ml,显著性高于口腔非典型增生组(15.43±2.35ng/ml)和正常对照组(11.29±4.78ng/ml)(P<0.05)。三组间TIMP-1水平及MMP-9/TIMP-1值无统计学差异。OSCC患者淋巴结转移组MMP-9水平为24.71±4.08ng/ml,显著高于未转移组的17.68±3.86ng/ml(t=6.77,P<0.01);肿瘤直径>3cm者MMP-9水平高于肿瘤直径≤3cm者(24.13±4.13ng/mlvs18.85±4.31ng/ml,t=4.84,P<0.01)。[结论]OSCC患者血清MMP-9水平显著升高,检测OSCC患者血清MMP-9水平有助于判断OSCC发生、转移。 [Purpose] To investigate the level of matrix metalloproteinase 9(MMP-9) and tissue inhibitor of metalloproteinase 1(TIMP-1) in oral squamous cell carcinoma(OSCC) and its significance. [Methods] The level of serum MMP-9 and TIMP-1 in 60 cases with OSCC preoperation, 26 cases with atypical hyperplasia of oral preoperation, and 30 healthy control was examined by ELISA. [Results] The level of serum MMP-9 in OSCC (21.67±4.21 ng/ml) was significantly higher than that in atypical hyperplasia of oral (15.43±2.35ng/ml) and healthy controls (11.29±4.78ng/ml) (P0.05). There wasn’t significantly difference in TIMP-1 level and MMP-9/ TIMP-1 value among the 3 groups. The level of serum MMP-9 in patients with lymph node metastasis was higher than that in patients without lymph node metastasis with significant difference (24.71±4.08ng/ml vs 17.68±3.86ng/ml; t=6.77,P〈0.01), and serum MMP-9 in patients with tumor diameter3cm was higher than that in patients with tumor diameter≤3cm (24.13±4.13 ng/ml vs 18.85±4.31 ng/ml; t=4.84,P〈0.01). [Conclusion] The level of serum MMP-9 is significantly increased in cases with OSCC. Detection serum MMP-9 might be helpful to predict occurrence and metastasis of OSCC.
出处 《肿瘤学杂志》 CAS 2011年第7期509-511,共3页 Journal of Chinese Oncology
关键词 口腔鳞状细胞癌 基质金属蛋白酶-9 基质金属蛋白酶抑制因子-1 oral squamous cell carcinoma matrix metalloproteinase 9 tissue inhibitor of metal-loproteinase 1
  • 相关文献

参考文献9

  • 1Becher N, Hein M, Uldbjerg N, et al. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug esti- mated by determination of free non-complexed TIMP [J]. Reprod Biol Endocrinol, 2008,6:45.
  • 2Vasala K, Paakko P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis [J]. Anticancer Res,2008 ,28(3B):1757-1761.
  • 3Gonzalez LO, Corte MD, Vazquez J, et al. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast[J]. Histopathology, 2008, 53(4):403-415.
  • 4sagindikova GE, Kogan EA, Satbaeva EB. Immunohisto- chemistry of matrix metalloproteinases in different morpho- logic types of the lung cancer developed in the inhabitants of the Semipalatinsk Region[J]. Arkh Patol, 2008, 70(1):26-29.
  • 5Annabi B, Rojas-Sutterlin 5, Laroche M, et al. The diet- derived sulforaphane inhibits matrix metalloproteinase-9- activated human brain microvascular endothelial cell mi- gration and tubulogenesis [J]. Mol Nutr Food Res, 2008, 52(6):692-700.
  • 6Shiratsuchi T , Ishibashi H, Shirasuna K. Inhibition of epi- dermal growth factorinvasion by dexamethasome and AP-1 decoy in human squamous cell carcinoma cell line [J]. J Cell Physiol, 2002,193(3): 340-348.
  • 7Kato K, Hara A, Kuno T, et al. Matrix metalloproteinas- es 2 and 9 in oral squamous cell carcinomas: manifesta- tion and localization of their activity[J]. J Cancer Res Clin Oncol, 2005, 131(6):340-346.
  • 8Watanabe M, Takahashi Y, Ohta T, et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinasc 1 gene in mude mice [J]. Cancer, 1996, 77(8 Suppl): 1676-1680.
  • 9Jinga DC, Blidaru A, Condrea I, et al. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors[J]. J Cell Mol Med, 2006,10(2):499-510.

同被引文献15

  • 1Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis[ J]. Cancer Chemother Pharmacol,1999,43( Sup-pl) :42-51.
  • 2Brew K, Dnakarpandian D, Nagase H. Tissue inhibitors of met-alloproteinases : evolution, structure and function [ J ]. Biochim Biophys Acta, 2000,1477 (12) : 267 -283.
  • 3Luo HI, Zhou ZG, Yang L,et al. Clinicopathologic and prognostic significance of MMP-7 ( matrilysin ) expression in human rectal cancer[J]. Jpn J Clin Oncol,2005 , 35 ( 12) : 739 - 744.
  • 4Pfaffl MW,Horgan GW, Dempfle L. Group-wise comparison and statistical analysis of relative expression results in real-time PCR [J]. Nucleic Acids Res, 2002,30(9) : e36.
  • 5Volper OL, Hopwood D, Newman EL, et al. Combined analysis of p53 and TSP-I in nonsmall cell carcinoma [ J ]. Oncogene, 1997, 14:1495.
  • 6Davies H,Waxmati J,Waxan H,et al. Levels of matrix metallo-fnolHJiusoN in “Hr cancer correlate with tumor grade and invasion!^ J !, (^atifrr [ins, 1993 , 84: 841 -850.
  • 7A1|ht 0, Bri^iiiiinn-LtMlner ES, Bennett TA, et al. Epidermal grow lb factor receptor signaling and the invasive phenotype of o-variaa carcinoma ceils [ J J. J Nall Cancer Inst, 2001,93 ( 18): 1375 - 1384.
  • 8Pesla M , Kulda V , Kucera H, et al. Prognoslic- significance of TIMP-1 in iton-small cell lung cancer [ J ]. Anticancer Res, 2011,3(41) ;4031 -4038.
  • 9Murra1,Duncan ME, Arbuckle E, et al. Matrixmetalloprotei-nases and their inhibitors in gastric (-ancer [ J ]. Gut, 1998,43(6): 791 -797.
  • 10Cai QW, Ij J, Li XQ, et al. Expression of sTATS, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological ieature? [J].Mol Med Report,2012,5(6) ; 1438 -1442.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部